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Abstract
Purpose To investigate the feasibility of deriving expe-
rience-based visual analogue scale (VAS) values for EQ-
5D-3L health states using national general population
health survey data in China.
Methods The EQ-5D-3L was included in the National
Health Services Survey (n = 120,709, aged 15–103 years) to
measure health-related quality of life. The respondents reported
their current health status on a VAS and completed the EQ-5D-
3L questionnaire, enabling modelling of the association
between the experience-based VAS values and self-reported
problems on EQ-5D dimensions and severity levels.
Results VAS values were generally negatively associated
with problems reported on the EQ-5D dimensions, and the
anxiety/depression dimension had the greatest impact on
VAS values. A previously obtained value for dead allowed
the values for all 243 EQ-5D-3L health states to be trans-
formed to the 0–1 scale (0 = dead, 1 = full health).
Conclusions This study presents the feasibility of deriving an
experience-based VAS values for EQ-5D-3L health states in
China. The analysis of these VAS data raises more fundamental
issues concerning the universal nature of the classification
system and the extent to which Chinese respondents utilise the
same concepts of health as defined by this classification system.
Keywords China  EQ-5D  Experience-based values 
General population  Health status  Visual analogue scale
Abbreviations
QALY Quality-adjusted life year
HRQoL Health-related quality of life
NHSS National Health Services Survey
SG Standard gamble
RS Rating scale
VAS Visual analogue scale
TTO Time trade-off
OLS Ordinary least square
MAD Mean absolute difference
SCC Spearman rank correlation coefficients
Background
EQ-5D is a widely used generic health-related quality of
life (HRQoL) instrument [1], with applications in clinical
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studies, economic evaluation of health care [2] and in
population health surveys [3]. It is recommended by the
UK National Health Service (NHS) as a health outcomes
measure for use by clinicians and managers [4]. In China,
there is an increasing interest in applying EQ-5D, both
amongst patients [5, 6] and the general population [7–10].
EQ-5D-3L (with five dimensions and three severity levels)
defines a classification of 243 health states and was
included in the National Health Services Survey (NHSS)
2008 in China, and population norms have been established
by age, sex, socioeconomic status [8] and geographic area
[9].
EQ-5D-3L health states represent a nominal level of
measurement since they cannot be ordered and have no
intrinsic quantitative score. In order to convert such a
classification into a cardinal scale with true arithmetic
properties, it is necessary to devise a system whereby
individual health states can be assigned an index value.
Methods for deriving scores for use in economic evaluation
must take into account several important methodological
considerations, in particular, which valuation method
should be used and whose values should be applied. Many
methods have been used to obtain health state values
including: standard gamble (SG), time trade-off (TTO) and
rating scale (RS) [2]. Both TTO and RS (visual analogue
scale (VAS)) have been used for obtaining EQ-5D value
sets [11, 12], and recently, the discrete choice method was
tested [13]. However, none of these methods is recognised
as being the standard measure for valuing health in eco-
nomic evaluations [2, 14].
Similarly, there are differences of opinion as to whose
values should be used [14–17]: experience-based values are
based on assessments made by individuals who are actually
in the health state; hypothetical values are based on
assessments of health state descriptions. Experience-based
values for EQ-5D-3L health states have been investigated,
both for TTO [16, 18, 19] and VAS [16, 18, 20–22]. Pre-
vious studies have shown that the experience-based values
tend to be higher than hypothetical values [15, 16, 22–28],
and the anxiety/depression dimension seems to be more
important when values are experience-based [16, 22–25].
For EQ-5D valuation studies based on hypothetical values,
in general, the VAS values are higher than those using TTO
values [12, 29]. As far as is known, only two studies [16,
18] have reported both TTO and VAS values from the
same respondents using experience-based values.
The aim of the present study is to investigate the fea-
sibility of deriving experience-based VAS values for EQ-
5D-3L health states using national general population
health survey data in China.
Materials and methods
Material/study population
Data are obtained from the National Health Services Sur-
vey 2008 (NHSS 2008), which is organised by the Ministry
of Health (MoH). A multi-stage stratified cluster random
sampling method was used, in total, 177,051 respondents
were face-to-face interviewed. Of these, about 18 % aged
below 15 years were excluded. Respondents needing
assistance in answering questions were excluded (13 %) as
were those who had missing answers on age, sex, in at least
one of the EQ-5D dimensions and on VAS. These
accounted for a further 2 %. For 6 respondents with a
profile of 11111 and VAS higher than 100, their VAS value
were imputed as 100. After applying these criteria, 120,709
respondents were available for further study. The NHSS
sampling design was examined by the MoH for all waves
of the surveys, and the representativeness of the sample
was considered good, i.e., proportions of the population
from different regions, age, sex and socio-economic
structures are representative of the Chinese population and
are similar to the census data, except for the unemployment
rate, which might be due to different ways of defining
unemployment [30].
Details regarding questionnaire, sampling method,
interview procedure can be found elsewhere [8, 9]. The
value for dead was obtained from the Household Health
Survey 2010 (n = 8,031), which used a similar protocol as
the NHSS 2008.
The EQ-5D-3L instrument classifies respondents’ health
status in five dimensions (mobility, self-care, usual activi-
ties, pain/discomfort and anxiety/depression), with three
severity levels (no problems, some problems and severe
problems), which in total defines 243 health states [1]. The
VAS consisted of a horizontal 11 cm line where every
tenth was marked and labelled 0, 10, 20, …, 100, with
anchor points 0 (worst health state) and 100 (best health
state). The question was framed: ‘On the scale please point
out which point best represents your own health state
today’. Respondents were asked to record their value for
the state ‘dead’ using the same VAS. The question was
framed: ‘This scale is the same as the one you saw before.
On this scale, where would you score dead?’ The scale was
harmonised to fit in the NHSS questionnaire and hence
differs from the EQ VAS.
Ethical permissions have been granted by the Regional
Ethics Committee, Stockholm, Sweden for the studies
(Dnr: 2009/1892-31/5, for NHSS 2008; Dnr: 2011/581-
31/5, for HHS 2010).
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Data analyses
All statistical analyses were performed using SAS version
9.2 [31], using a 5 % significance level. Ordinary least
square (OLS) was used for all regression analysis. Defini-
tion of variables and models are presented in Table 1. A
structured approach to data analysis was taken in which a
basic main effects model was specified using two dummy
variables for each of the five dimensions. The performance
of alternative models was examined in which interaction
terms were included with a view to improving model
performance. Interaction terms were included as follows: if
any dimension is on level 2 or 3 (N2 and N3, respectively),
number of dimensions at level 2 or 3 beyond the first one
and the square term of it. However, only N3 leads to
consistent results, and therefore, we only present models
with N3 term.
A primary requirement for any estimation model is that
coefficients are monotonically consistent within dimen-
sions so that value loss increases as the level of problem
becomes greater. Firstly, we tested the models with the ten
dummy variables (Model 1). However, the coefficient for
moderate problems on self-care dimension (SC2) was
positive; therefore, we tested N3 term, but SC2 was still
positive. Two further sets of models were tested. In Models
3 and 4, SC2 was excluded, and thus for self-care dimen-
sion, the levels 1 and 2 were merged into one category in
the reference group and the coefficient for self-care level 3
was then represented by SC3*. In Models 5 and 6, for self-
care dimension, the levels 2 and 3 were merged into one
category, by including a new dummy variable SC23.
F-tests were used to make comparisons between the models
with and without the N3 term.
For models based on individual-level data, raw VAS
value was used as the dependant variable in the OLS
models. Due to the skewed distribution of data, we have
tested OLS models with log-transformed VAS [32]. Fur-
thermore, we also performed Poisson, negative binomial
[21, 33], Tobit [34] and quantile models [35]. However,
compared with the OLS models, these did not provide
better results, in terms of monotonicity and goodness of fit;
therefore, we only present OLS models with raw VAS
value.
The survey dataset contains multiple ratings from sep-
arate individuals who classify themselves in the same EQ-
5D health state. For these health states, it is possible to
compute a mean rating which represents the average VAS
value associated with that specific health state. Step-wise
Table 1 Definition of variables
and models
Variable Definition
MO2 1 If mobility is level 2; 0 otherwise
MO3 1 If mobility is level 3; 0 otherwise
SC2 1 If self-care is level 2; 0 otherwise
SC3 1 If self-care is level 3; 0 otherwise
SC3* 1 If self-care is level 3; 0 otherwise
(merged levels 1 and 2 in the reference group)
SC23 1 If self-care is level 2 or 3; 0 otherwise
UA2 1 If usual activities is level 2; 0 otherwise
UA3 1 If usual activities is level 3; 0 otherwise
PD2 1 If pain/discomfort is level 2; 0 otherwise
PD3 1 If pain/discomfort is level 3; 0 otherwise
AD2 1 If anxiety/depression is level 2; 0 otherwise
AD3 1 If anxiety/depression is level 3; 0 otherwise
N3 1 If any dimension is level 3; 0 otherwise
Models f(x)
Models based on individual data
Model 1 f (mo2 mo3 sc2 sc3 ua2 ua3 pd2 pd3 ad2 ad3)
Model 2 f (mo2 mo3 sc2 sc3 ua2 ua3 pd2 pd3 ad2 ad3 N3)
Model 3 f (mo2 mo3 sc3* ua2 ua3 pd2 pd3 ad2 ad3)
Model 4 f (mo2 mo3 sc3* ua2 ua3 pd2 pd3 ad2 ad3 N3)
Model 5 f (mo2 mo3 sc23 ua2 ua3 pd2 pd3 ad2 ad3)
Model 6 f (mo2 mo3 sc23 ua2 ua3 pd2 pd3 ad2 ad3 N3)
Models based on aggregated data
Model 1M1–Model 1M3 f (mo2 mo3 sc2 sc3 ua2 ua3 pd2 pd3 ad2 ad3)
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sensitive analyses were taken, to investigate how many
observations were required in order to generate a ‘safe’
mean for each EQ-5D health state (results can be provided
on request). In this study, EQ-5D health states with 20 or
more observations were considered reasonable. Aggregate-
level analyses were carried out using models in which
mean VAS value for these health states were taken as the
dependent variable and the ten main effect dummy vari-
ables as the independent variables.
Selection of the final models is based on the following
criteria [36]: the model should be simple (parsimony),
should provide consistent results with an acceptable
goodness of fit and should be transparent so as to be able
to be understood by non-experts. Spearman rank correla-
tion coefficients (SCC) and mean absolute difference
(MAD) were used to examine the goodness of fit of the
models. Higher SCC and lower MAD indicates better
model fitting.
We employed a split sample test in order to estimate the
robustness of the final model. Furthermore, we explored the
effect of socio-demographic factors on health state valua-
tion. Details regarding the above analyses can be found in
online resource (QURE-S-14-00050_ESM.pdf).
Results
Characteristics of the sample, percentage of problems
reported on each EQ-5D dimension and mean VAS score
are presented in Table 2.
Table 2 Characteristics of the respondents
15–103 years (n = 120,709)
% n
Sex
Men 48.2 58,169
Women 51.8 62,540
Age group (years)
15–24 11.3 13,635
25–34 13.7 16,510
35–44 23.3 28,088
45–54 21.3 25,695
55–64 16.2 19,557
65–74 9.5 11,491
75–103 4.8 5,733
Region
Urban 27.7 33,447
Rural 72.3 87,262
Area
Eastern 35.1 42,305
Middle 27.5 33,175
Western 37.5 45,229
Marital status
Single 11.9 14,406
Married 79.2 95,649
Divorced 1.4 1,744
Widowed 7.1 8,605
Other 0.2 234
Missing 0.1 71
Educational level
Below primary school 15.6 18,841
Primary school 27.9 33,630
Junior middle school 35.7 43,042
Senior middle school 14.9 17,941
College and above 5.9 7,160
Missing 0.1 95
Income groups
First group (low) 22.8 27,560
Second group 21.6 26,037
Third group 18.9 22,791
Fourth group 17.7 21,417
Fifth group (high) 19.0 22,904
Occupational status
Employed 70.6 85,161
Retired 10.2 12,313
Student 4.4 5,322
Unemployed 14.6 17,627
Missing 0.2 286
EQ-5D dimension
Mobility
Moderate problems (level 2) 4.8 5,760
Table 2 continued
15–103 years (n = 120,709)
% n
Severe problems (level 3) 0.4 447
Self-care
Moderate problems (level 2) 2.8 3,413
Severe problems (level 3) 0.4 522
Usual activities
Moderate problems (level 2) 4.0 4,850
Severe problems (level 3) 0.8 978
Pain/discomfort
Moderate problems 8.8 10,661
Severe problems 0.4 500
Anxiety/depression
Moderate problems (level 2) 6.0 7,287
Severe problems (level 3) 0.4 467
Mean SD
VAS score 80.1 14.1
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The observed EQ-5D health states are presented in
online resource Supplementary Table S1. In total, 167 out
of the 243 possible EQ-5D health states were observed and
51 health states had 20 or more observations. The most
frequently occurred health state was 11111 (87 % of the
population), followed by 11121 and 11112. The mean VAS
value for 11111 was 82.6, which was 17 points below the
upper boundary of best health state. The mean VAS value
for 33333 was 34, which was 34 points above the lower
bound of worst health state.
Table 3 shows the coefficients produced by OLS based
on individual-level data. Models 1 and 2 included all the
ten dummy variables; the coefficients were monotonic
except for SC2. In Models 3 and 4, all coefficients were
monotonic. In Models 5 and 6, coefficient for self-care
dimension and N3 were positive. In Model 4, the N3 terms
Table 4 Regression analysis on
VAS values, EQ-5D
dimensions, aggregated data
a Health states with less than 20
observations are excluded
(number of health states = 51)
b Health states with less than 25
observations are excluded
(number of health states = 47)
c Health states with less than 30
observations are excluded
(number of health states = 43)
Model 1M1a Model 1M2b Model 1M3c
Estimate p value Estimate p value Estimate p value
Intercept 74.12 \0.0001 74.30 \0.0001 75.03 \0.0001
Mobility
Level 2 -4.49 0.0002 -4.53 0.0003 -4.92 \0.0001
Level 3 -5.88 0.0082 -4.77 0.0355 -4.63 0.0301
Self-care
Level 2 -0.78 0.4754 -0.60 0.6025 -0.85 0.3903
Level 3 -6.99 0.0028 -5.54 0.0264 -5.08 0.0397
Usual activities
Level 2 -4.85 0.0001 -5.11 0.0001 -5.50 \0.0001
Level 3 -9.79 \0.0001 -10.58 \0.0001 -11.04 \0.0001
Pain/discomfort
Level 2 -6.36 \0.0001 -5.96 \0.0001 -5.57 \0.0001
Level 3 -9.85 \0.0001 -10.23 \0.0001 -10.76 \0.0001
Anxiety/depression
Level 2 -5.13 \0.0001 -5.48 \0.0001 -5.65 \0.0001
Level 3 -12.39 \0.0001 -12.86 \0.0001 -15.27 \0.0001
Adjusted R2 0.9076 0.9136 0.9308
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Fig. 1 Observed values compared with predicted values from different OLS models for the most frequently occurred health states
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were negative and significant. However, the F-test did not
suggest that the Model 4 was significantly better than
Model 3.
Table 4 shows the coefficients produced by OLS based
on aggregated data. The coefficients are monotonic for all
dimensions in all models. For level 3, anxiety/depression
had the greatest coefficient, followed by pain/discomfort
and usual activities. For level 2, pain/discomfort had
largest coefficient, followed by mobility and anxiety/
depression. Overall, by excluding health states with fewer
observations in the analyses, the adjusted R2 improved
from Model 1M1 (0.91) to Model 1M3 (0.93).
The estimated values predicted by different models were
compared with the observed values (Fig. 1), and goodness-
of-fit statistics were reported (Table 5). For health states
with 20 or more observations, for individual-level data,
Models 3 and 4 performed the best; for aggregated data, it
was Model 1M1.
The parsimony, monotonicity criteria and F-test
(Table 3), and goodness-of-fit analyses (Table 5; Fig. 1)
suggested that for the individual-level data, Model 3 was
the best-fitting model; for the aggregated data, it was
Model 1M1. For Model 3, the intercept was 82.4, corre-
sponded to the observed mean value for health state 11111
(82.6). Coefficients for level 3 and level 2 were compared
in absolute terms. For level 3, the greatest coefficient was
seen for anxiety/depression (16.6), followed by pain/dis-
comfort (14.0) and usual activities (11.2). For level 2, the
greatest coefficient was seen for pain/discomfort (11.1),
followed by anxiety/depression (8.4) and mobility (6.5).
For Model 1M1, the intercept was 74.1, which was about 9
points lower than the observed value for 11111. For level 3,
the greatest coefficient was seen for anxiety/depression
(12.4), followed by pain/discomfort (9.9) and usual activ-
ities (9.8). For level 2, the greatest coefficient was seen for
pain/discomfort (6.4), followed by anxiety/depression (5.1)
and mobility (4.5).
Based on Model 3 (individual-level data) and Model
1M1 (aggregated data), VAS values for all the 243 EQ-5D-
3L health states can be calculated. The VAS had the end-
points worst and best health state, which did not allow for
anchoring between 0 (dead) and 1 (full health). For using
VAS values in quality-adjusted life year (QALY) calcula-
tions, rescaling by the value for dead is needed. In this
present study, the value for dead was obtained from the
Household Health Survey 2010. The mean value for dead
was 4.5. So as to rescale the estimated VAS values on a
0–1 metric, the formula (VASEstimated - deadmean)/
(VAS11111 - deadmean) [11] was used. The estimated and
rescaled VAS values for 243 EQ-5D health states are
presented in Table S2 in online resource.
Discussion
Our study reports on the estimation of experience-based
VAS values for EQ-5D-3L health states, using data from a
large national cross-sectional population-based survey
conducted in China. In the NHSS 2008, individuals reported
their current health status using the EQ-5D descriptive
system and valued their health using VAS. Appropriate
sampling methods were used to recruit a national repre-
sentative sample, which is the strength of our study. Fur-
thermore, by utilising a previously obtained value for dead,
we are able to transform values for all the 243 EQ-5D health
states to a 0–1 scale (0 = dead; 1 = full health).
Table 5 Spearman rank
correlation coefficients (SCC)
and mean absolute difference
(MAD)
Observations in each
health state
Number of
health states
Individual-level data
Model 1 Model 2 Model 3 Model 4
Corr MAD Corr MAD Corr MAD Corr MAD
n C 1 167 0.686 7.55 0.676 7.51 0.687 7.53 0.677 7.48
n C 20 51 0.945 4.14 0.946 3.97 0.945 4.10 0.947 3.92
n C 25 47 0.950 4.07 0.951 3.91 0.951 4.03 0.952 3.87
n C 30 43 0.952 3.90 0.951 3.84 0.953 3.85 0.952 3.78
Observations in each health
state
Number of health
states
Aggregated data
Model 1M1 Model 1M2 Model 1M3
Corr MAD Corr MAD Corr MAD
n C 1 167 0.668 7.02 0.643 8.83 0.655 8.88
n C 20 51 0.960 2.30 0.871 6.13 0.864 6.72
n C 25 47 0.962 2.23 0.871 6.13 0.865 6.70
n C 30 43 0.964 1.99 0.861 5.95 0.855 6.63
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In China, 167 out of 243 EQ-5D health states were
observed; this number is higher than that recorded in
Sweden (148) [16] and UK (139) [20], where experience-
based VAS values were also used to derive values for EQ-
5D-3L health states. That more health states were observed
in this study than in Sweden and UK, might be due to the
larger sample size of the Chinese survey. In all countries,
the most frequently occurring health state was 11111,
followed by 11121. For China and UK, 11112 was the
third; for Sweden, it was 11122. Nearly, 87 % of the
respondents reported 11111 in China, higher than UK
(45 %), Sweden (42 %) and Germany (66 %) [21]. The
rate of respondents reporting no problems on EQ-5D
dimensions in this present survey is roughly double the rate
observed elsewhere and warrants further investigation.
Anxiety/depression has the greatest impact on overall
HRQoL, as suggested in other studies in which experience-
based values were used [16, 21, 22]. The difference
between hypothetical values and experience-based values
might be due to adaptation, contrast effects and shifting
comparisons [19]. In the hypothetical valuation, the
respondents might over-estimate loss in health as they
underestimate the adaptation, and focus on transitory
change from one health state to another [24]. Our study is
in line with previous studies [15, 16, 18, 22–28] and shows
that the experience-based values tend to be higher than
hypothetical values. The use of experience-based values in
an intervention may seemingly lead to a smaller gain
comparing with if values were based on hypothetical health
states. If this is an underestimation of the gain depends on
whose preferences are considered most suitable.
Several estimation models produced evidence of non-
monotonicity, which was encountered by other studies as
well [16, 20, 37–39]. By merging self-care levels 1 and 2,
the results are more logical; however, the index value is
insensitive to the difference between levels 1 and 2 on self-
care dimension. The reason for the observed non-monoto-
nicity probably stems from construct–irrelevant variance or
construct underrepresentation. We observed that a few
respondents (1 %) reported problems on EQ-5D dimen-
sions, yet had a VAS value at 100 (best heath); some
respondents reported no problem, but reported a very low
VAS value. This might due to misunderstanding, mea-
surement noise, or that respondents actually valued own
health state like that. As it is difficult to define what could
be the most reasonable range of VAS value for a certain
health state, we included all the answers in the analysis.
Another issue is regarding the inconsistent pairs in the
observed values, for example, 12222 is logically worse
than 11222, but we observed a higher value for 12222 than
11222. We have identified all these kinds of logical
inconsistent pairs, most of them were due to the small
number of observation for that health state. That is also
why we only report SCC and MAD for the health states
with 20 or more observations. In our data, most inconsis-
tency pairs came from the self-care dimension. The non-
monotonicity for the self-care dimension might be due to
the above reason, but also the skewness of the data, multi-
collinearity and heteroscedasticity might contribute to that
[20, 37].
The valuations for respondent’s own health seen in the
data collected in this study suggest a truncated use of the
VAS rating scale, with gaps evident at both the higher and
lower range. Respondents who self-classify as being in the
11111 health state report a mean VAS rating that is some
17 points less than the defined value assigned to best
imaginable health. Similarly, the high value for dead cre-
ates a 34 point gap between dead and worst imaginable
health. This discontinuity in values might be a result of the
valuation method itself, or a by-product of the descriptive
classification. Whatever is the cause, it suggests that there
are other mechanisms at work here that are yet poorly
understood.
Taken together, these results suggest that there might be
health domains additional to those specified as EQ-5D
dimensions [20, 40], so that respondents might not consider
that 11111 is in fact the best (or even best imaginable)
health state [41]. The high proportion of respondents
reporting 11111 in China might be attributable to many
causes linked to the EQ-5D descriptive classification, for
example at a purely technical level, the process of trans-
lation may have introduced incorrect meaning to the health
problem descriptions. However, this seems unlikely
although the hugely skewed distribution of responses
would be consistent with the presence of an intrinsic design
flaw.
Given the magnitude of the phenomenon, it may be that
the model of health that provides the conceptual foundation
of EQ-5D is simply not recognised by respondents with the
Chinese or other East Asian culture background in the
same way that it is by (say) respondents with purely
Western European or North American culture background
[3, 7, 40, 42, 43]. Culture can impact respondents answers
from several perspectives [44]. For example, the numbers
might be used differently cross different cultures, e.g.,
whether or not 100 on a VAS scale means the same thing
across different cultures; or some items might function
differently in different cultures, e.g., comparing with the
English, Spanish and French respondents, the Chinese
respondents consider the word ‘moderate problems’ rep-
resenting more severe degree than other countries [45].
Whilst the EQ-5D dimensions themselves may appear to be
relevant in describing health, the concept of varying
degrees of problems within each dimension might not be
recognised in the same way. Additional exploration of the
concept of ‘health’ in China also seems necessary.
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Both TTO and VAS have been adopted as valuation
methods for eliciting values for the EQ-5D health states
[11, 12]. VAS value sets are available for Belgium [46],
Malaysia [47] and Europe [32]. VAS might be considered
to be inferior to TTO, as it is not a choice based measure
[2]; however, other views can be seen as well [48, 49]. If
QALY is applied in non-economic evaluation, such as
monitoring health status change of a population, then there
is no requirement that the quality–adjustment factor must
be a utility measure [20]. As stated by the EuroQoL Group
that ‘the theoretical and empirical case for favouring one
method of health state valuation over another is far from
clear cut. In practice, there are currently no EQ-5D value
set generated from SG methods, so for users the choice is
between TTO and VAS’ [11]. The focus of the present
study is to raise methodological issues, and further inves-
tigations are needed; hence, the rescaled values from this
study should not be treated as EQ-5D tariff.
The presentation of results based both on the analysis of
individual-level data and the aggregated data for observed
health states raises important questions for analysts and
decision-makers. Theoretically, the analyses based on
individual-level data are expected to produce better results
as they take each individual’s information into consider-
ation. However, this approach relies upon there being
reasonable parity amongst the health states under consid-
eration. In valuation studies based on hypothetical health
states, considerable care will be taken in selecting the states
to ensure roughly comparable coverage per dimension/
level. In a study based on experience-based health states,
however, such control of design is infeasible. The fact that
the vast majority of respondents report having no problem
on any of the EQ-5D dimensions resulted in a skewed
distribution of data, which in itself presents problems,
especially with low frequencies of reported problems evi-
dent for some dimensions such as self-care and mobility.
This has implications for the design of any study that seeks
to establish experience-based values. Estimating a model
based on aggregated data has the twin advantage of
smoothing the variability of VAS values present for each
state whilst at the same time reducing the potential
swamping of minority health states by the overwhelming
presence of the 11111 health state. Of course, there are
drawbacks to this approach, notably in estimating mean
values for health states with relatively few observations.
This naturally raises the question as to how many obser-
vations are required in order to generate a ‘safe’ mean. We
have tried some sensitive analysis in this study, however, to
which extend it fits the requirement of power calculations
based on statistical theory and how important that is, is for
further research. But as long as we are cautious in our
interpretation of results, we can still make progress with
our understanding. In this study, for individual-level data,
Model 3 performed best. However, by merging self-care
levels 1 and 2, the index value is insensitive to the dif-
ference between levels 1 and 2 on self-care dimension, and
for example, 11111 and 12111 would have the same index
value [21]. For aggregated data, Model 1M1 performs best,
however, the big gap between the estimated value and the
observed value for the health state 11111 is problematic,
which needs further investigation. The purpose of the
present study was to help us gain a better understanding of
the methodological issues that confront us in developing a
mechanism for valuing EQ-5D health states using experi-
ence-based VAS values. Hence, it would be premature to
suggest at this early stage that whether models based on
individual-level or aggregated data should dominate.
Some general issues need to be addressed, limitations
regarding sampling design, interviewer bias, definitions of
socio-demographic factors and ceiling effect have been
discussed elsewhere [8, 9]. Despite the above, there are
limitations of modelling specification. As data were nega-
tively skewed, the assumption of normality does not hold;
though the estimates of parameters will still be consistent,
the standard-error estimates will be inconsistent in small
samples [50]. As there is correlation amongst the main
effect dummy variables, models might suffer from multi-
collinearity, heteroscedasticity and logically inconsistent in
parameter estimates [16, 50, 51]. The potential extra health
dimension might affect VAS values, and it might also be
correlated with the EQ-5D dimensions, which can lead to
bias in the estimations.
This study presents the feasibility of deriving an expe-
rience-based VAS values for EQ-5D-3L health states in
China. The analysis of these VAS data raises more fun-
damental issues concerning the universal nature of the
classification system and the extent to which Chinese
respondents utilise the same concepts of health as defined
by this classification system. Further investigation is nee-
ded regarding how the mode of administration, face-to-face
interviews and the design of the VAS might influence
responses. Additional analysis of these important popula-
tion health survey data and qualitative studies may improve
our understanding of these results but if, as seems probable,
satisfactory explanations are not identified then more tar-
geted studies of EQ-5D-3L focussing on these methodo-
logical issues would be justified.
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